Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Liver Neoplasms

3,4-methylenedioxyamphetamine has been researched along with Liver Neoplasms in 3 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, H1
Lan, H1
Zhang, M1
Zhao, F1
An, N1
Yi, C1
Henderson, MJ1
Zwerling, I1

Other Studies

3 other studies available for 3,4-methylenedioxyamphetamine and Liver Neoplasms

ArticleYear
TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
    Digestive diseases and sciences, 2023, Volume: 68, Issue:7

    Topics: 3,4-Methylenedioxyamphetamine; Carcinoma, Hepatocellular; Ferroptosis; Humans; Liver Neoplasms; Reac

2023
Remembering Sophie.
    Advance for nurse practitioners, 2006, Volume: 14, Issue:9

    Topics: Aged, 80 and over; Humans; Liver Neoplasms; Love; Nurse Practitioners; Nurse-Patient Relations; Term

2006
A single intervention: a visit to the family.
    Family process, 1980, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Child; Colonic Neoplasms; Crisis Intervention; Family; Father-Child Relations; Fe

1980